Symbiotec Pharmalab Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Jun-26 | Sep-26 |
|---|---|---|
| 218 | 280 | |
| 0.34 | 0.11 | |
| 201 | 216 | |
| 103 | 80 | |
| −27 | — | |
| 46 | 47 | |
| 6 | 6 | |
| 22 | 22 | |
| 51 | 62 | |
| 46 | 92 | |
| 24 | 70 | |
| 18 | 64 | |
| 3 | 12 | |
| 14 | 52 | |
| Financial ratios | ||
| 20.87% | 32.73% | |
| 6.45% | 18.48% | |
| 2.24 | 8.20 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.